Fig. 6.
Fig. 6. Meg-01 cell Bcl-2 and Bax expression. / (A) Western blot analysis of Bcl-2 expression in Meg-01 cell lysates after treatment with 100 μmol/L GSNO for varying times. Lane 1, untreated cells; lane 2, 1 hour of treatment; lane 3, 2 hours of treatment; lane 4, 4 hours of treatment. (B) Western blot analysis of Bax expression in Meg-01 cell lysates after treatment with 100 μmol/L GSNO for varying times. Lane 1, untreated; lane 2, 1 hour of treatment; lane 3, 2 hours of treatment.

Meg-01 cell Bcl-2 and Bax expression.

(A) Western blot analysis of Bcl-2 expression in Meg-01 cell lysates after treatment with 100 μmol/L GSNO for varying times. Lane 1, untreated cells; lane 2, 1 hour of treatment; lane 3, 2 hours of treatment; lane 4, 4 hours of treatment. (B) Western blot analysis of Bax expression in Meg-01 cell lysates after treatment with 100 μmol/L GSNO for varying times. Lane 1, untreated; lane 2, 1 hour of treatment; lane 3, 2 hours of treatment.

Close Modal

or Create an Account

Close Modal
Close Modal